| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.13 | 0.5 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |